UPDATED Jun 16, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
300723 | CN¥22.11 | -1.4% | -25.9% | CN¥9.9b | CN¥30.72 | PE57.1x | E29.3% | 0.9% | Pharmaceuticals & Biotech | ||
603171 | CN¥21.63 | 4.3% | -49.7% | CN¥8.8b | CN¥36.63 | PE104.7x | E48.7% | 0.7% | Software | ||
300223 | CN¥60.93 | 5.4% | -35.0% | CN¥29.3b | CN¥62.63 | PE57.6x | E28.9% | 0.3% | Semiconductors | ||
2123 | CN¥7.67 | 4.5% | -46.5% | CN¥6.1b | CN¥13.49 | PS1.2x | E112.4% | 0% | Software | ||
7069 | JP¥1,766.00 | 15.3% | 30.3% | JP¥7.1b | n/a | PS1x | E48.0% | n/a | Media |